Biotech | February 19, 2022
cbdMD becomes first American CBD brand to receive UK validation
The company will now be allowed to sell its proprietary and validated tinctures, gummies, and capsules across the UK
The company will now be allowed to sell its proprietary and validated tinctures, gummies, and capsules across the UK
AMX0035 is an investigational therapy for the treatment of amyotrophic lateral sclerosis (ALS).
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Canada
More than 2,500 submissions are currently under review in the Food and Drug Administration's (FDA) cell and gene therapy pipeline
Immune responses were about two-to-three-fold higher in adolescents than in adults against all variants studied. Vaccine was well-tolerated with no safety signals identified
Adds five years of market exclusivity on approval
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
Spikevax has received approval by regulators in more than 70 countries, including Canada, Japan, the European Union, the UK, Israel
It would be the first protein-based alternative available in Israel
The vaccines are currently only authorised for emergency use in the country
Subscribe To Our Newsletter & Stay Updated
